Category: Public

Navellier Top 5 Stocks for October

he following is provided by Navellier with technical comment from South Ocean Management – pls do your own due diligence.
(For this 2020 year, SOM will track only the Top 5 Hi-Growth Investments.)

https://navelliergrowth.investorplace.com/

Navellier says,

High-Growth Investments

DocuSign, Inc.

DocuSign, Inc. (DOCU) is one of the hottest stocks in the Growth Investor Buy Lists, as the stock has climbed an impressive 60% in the past four months. The reality is that the company has fared well during the global pandemic given that many folks are afraid to sign documents; whether it’s a reluctance to visit an office or the potential for germs on pens.

As a result, many have turned to DocuSign to utilize their e-signature technologies. You may recall that DocuSign offers a cloud-based platform that enables businesses and individuals to develop, upload, sign and send agreements and documents virtually. And its technology can be integrated with several solutions, including Salesforce and Workday.

So, it’s not surprising that DocuSign posted incredible results for its second quarter in fiscal year 2021. The company reported total revenue of $342.2 million and earnings of $0.17 per share, which represented 45% annual revenue growth and 1,600% annual earnings growth. Analysts were expecting earnings of $0.08 per share, so DocuSign posted a whopping 112.5% earnings surprise.

Following the better-than-expected earnings report, analysts started to up their third-quarter earnings outlook. Earnings are now expected to grow 18.2% year-over-year to $0.13 per share, and revenue is forecast to rise 44.6% year-over-year to $360.87 million. DOCU is a Moderately Aggressive buy below $235.

SOM Technicals:

6-26-20: Closed at 177.58. Trade pressures are up. Volumes are bullish. This spike up is not likely to continue in the face of the sell off.

7-4-20: Closed at 190.99. Trade pressures are up. Volumes are bullish. This parabolic move is very uncomfortable.

7-10-20: Closed at 210.11. Trade pressures are up but reversing. A close below 210 would signal lower.

7-18-20: Closed at 196.42. Trade pressures are down but rising. Volumes are neutral. The next target up is 217.

7-24-20: Closed at 190.95. Trade pressures are down. Volumes are bearish. The next target down is 172.23.

7-30-20: Closed at 217.45. Trade pressures are up. Volumes are bullish. The next target up is 257.20.

8-7-20: Closed at 205.00. Trade pressures are down. Volumes are bearish. Dropped thru two downside targets this week. The next target down is 185.06.

8-15-20: Closed at 199.71. Trade pressures are neutral. Volumes are neutral also. Traded down near the 185.06 target and now has moved higher. At the 25×5 MA and looks lower. The next target don is the 185.91 Target.

8-21-20: Closed at 210.18. Trade pressures are up but showing reversal. Volumes are bullish. The next target up is 221.00.

8-29-20: Closed at 215.24. Trade pressures are up. Volumes are bearish. resistance here at the 217.23 level, which is also the new long entry.

9-5-20: Closed at 216.26: Trade pressures are down. Volumes are bearish. Sitting on the 25×5 MA support at 216.

9-12-20: Closed at 197.94. Trade pressures are down. Volumes are bearish. A close below 196.53 triggers a new short entry.

9-19-20: Closed at 194.42. Trade pressures are down. Volumes are neutral. The next target down is 173.35.

9-26-20: Closed at 212.36. Trade pressures are down into the neutral zone. Volumes are bullish. The next target down is 173.35.

10-11-20: Closed at 225.80. Trade pressures are down into the neutral zone. Volumes are bullish. A close above 240 would signal higher.

10-17-20: Closed at 234.60. Trade pressure are up. Volume are bullish. The next target up is 300.00.

10-24-20: Closed at 219.82. Trade pressures are down but reversing. Volumes are bearish. The next target down is 195.29.

 

Genmab A/S

Genmab A/S (GMAB) is a biotechnology company that’s focused on developing antibody therapeutics to treat cancer. Currently, Genmab has two products on the market: DARZALEX, or Daratumumab, to treat multiple myeloma and Arzerra, or Ofatumumab, to treat specific indications of chronic lymphocytic leukemia.

Recently, Janssen Biotech, Inc. submitted a supplemental Biologics License Application (sBLA) for Genmab’s DARZALEX FASPRO with the FDA. The application will be reviewed by the FDA under Project Orbis and RTOR pilot program to determine if the treatment is a viable option for adults with light-chain (AL) amyloidosis. With the submission of the sBLA, Genmab receives an $8 million milestone payment.

Thanks to rising demand for its antibody therapeutics, vast clinical pipeline and strategic partnership with AbbVie, Genmab has strong forecasted sales growth and earnings estimates have been revised higher over the past three months. Third-quarter sales are expected to soar 55.8% year-over-year to $241.41 million. Earnings per share estimates have been upped 91.7% in the past three months, which bodes well for a third-straight quarterly earnings surprise. GMAB is a Conservative buy below $39.

SOM Technicals:

9-26-20: Closed at 36.02. Trade pressures are down but rising. Volumes are neutral. The next target down is 33.20.

10-11-20: closed at 37.46. Trade pressures are up. V olumes are neutral. Trade down to the 34.28 down side target then rallied. Still in the down trend but a close above 38.52 changes to uptrend.

10-17-20: Closed at 36.79. Trade pressures are down but reversing. Volumes are neutral. At supprort.

10-24-20: Closed at 35.67. Trade pressures are down and basing. Volumes are bullish. The next target down is 34.28.

 

Novavax, Inc.

Novavax, Inc. (NVAX) was one of our September additions to the High-Growth Investments Buy List. If you recall, the company develops vaccines for the toughest viruses in the world. Novavax currently has a strong pipeline of vaccine candidates, including several that are in Phase 2 and 3 clinical trials. But its coronavirus vaccine candidate is one of the main reasons why we added the stock to the Buy List.

Novavax’s vaccine candidate is being funded by both the federal government through Operation Warp Speed and the Bill & Melinda Gates Foundation. Thanks to positive Phase 1 results, the company has started multiple Phase 2 clinical trials, including in the U.S. and Australia. And Canada recently announced that it will purchase up to 76 million doses of Novavax’s vaccine.

Given the success of its early clinical trials and countries knocking on its door for the approved vaccine, the analyst community has aggressively increased their third-quarter earnings outlook. Analysts are expecting earnings of $1.83 per share, up from previous estimates for an earnings per share loss of $0.10. As you know, positive earnings revisions typically precede future earnings surprises. NVAX is an Aggressive buy below $181.

SOM Technicals:

9-26-20: Closed at 113.56. Trade pressures are up. Volumes are bullish. The next target up is 129.69.

10-11-20: Closed at 111.12. Trade pressures are up and trending. Volumes are buillish. The next target up is 129.00. 

10-17-20: Closed at 107.04. Trade pressures are down. volumes are bearish. A close below 101 would signal lower.

10-24-20: Closed at 93.13. Trade pressures are down and trending. Volumes are bullish. the next target down is 73.45.

 

Quidel Corporation

With more primary schools and universities opening their doors, the need for coronavirus testing kits is growing exponentially. In fact, my daughter attends Cornell University, and they continually check her for the virus (negative results each time). One of the biggest beneficiaries of all the coronavirus testing is our own Quidel Corporation (QDEL), which developed the SARS-CoV-2 test for COVID-19.

According to a recent article from Reuters, U.S. manufacturers are ramping up production on COVID-19 tests, looking to achieve 100 million test each month by the end of year. Quidel, along with Abbott Labs, Becton Dickinson & Co. and LumiraDX, all received authorization for their antigen tests. Quidel actually received an emergency use authorization (EUA) from the FDA for its SARS-CoV-2 test earlier this year.

As a result, analysts are anticipating blowout third-quarter results. The consensus estimate calls for earnings of $4.06 per share, or 480% annual earnings growth, and revenue of $394.28 million. Analysts have also increased earnings by an incredible 80.4% in the past three months, so a fifth-straight quarterly earnings surprise is likely. QDEL is an Aggressive buy below $237.

SOM Technicals:

7-30-20: Closed at 282.47. Trade pressures are up. Volumes are bullish. The next target up is 367.57.

8-7-20: Closed at 272.76. Trade pressures are down. Volumes are bearish. The next target down is 259.83 the 25×5 MA.

8-15-20: Closed at 245.93. Trade pressures are up. Volumes are bearish. At the 25×5 MA. Should act as resistance. The next target down is 215.00.

8-21-20: Closed at 241.52. Trade pressures are in the neutral zone. Volume are bearish. Appears to want to test the 200.00 support level.

8-29-20: Closed at 162.97. Trade pressures are down hard. Volumes are neutral, short covering? The 200 day MA held as support. A close above 188.83 is the new long entry.

9-5-20: Closed at 154.41. Trade pressures are down. Volumes are bearish. 200 day MA is holding as support.

9-12-20: Closed at 161.19. Trade pressures are rising into the neutral zone. Volumes are now bullish. A close above 188.63 would signal higher.

9-19-20: Closed at 188.50. Trade pressures are up. Volumes are bullish. Has triggered a new long entry. The next target up is 248.00.

9-26-20: Closed at 196.77. Trade pressures are up but turning down. Volumes are bullish. The next target down is 161.41.

10-11-20: Closed at 278.05. (Nice  move while i was gone!) Trade pressures are up and trending. Volumes are bullish. The next target up is 290.43.

10-17-20: Closed at 255.25. Trade pressures are down. Volumes are bearish. A retest of the breakout. support at 223.

10-14-20: Closed at 248.21. Trade pressures are down and trending. Volumes are bearish. At the 239 support.

 

Zoom Video Communications, Inc.

Zoom Video Communications, Inc. (ZM) has certainly been one of the biggest beneficiaries of the global pandemic, as its online video and audio conference call platform has been a primary tool for companies to continue to do business. In fact, ZM shares defied broader market weakness earlier this week when the U.K. imposed a new round of restrictions and encouraged citizens to work from home. ZM shares are up more than 65% in the past four weeks alone, versus the S&P 500’s 6% decline.

Part of this strength came on the heels of a stunning second-quarter earnings reports. For its second quarter in fiscal year 2021, Zoom achieved revenue of $663.5 million and earnings of $274.8 million, or $0.92 per share, which represented 355% annual revenue growth and 1,045% annual earnings growth. The consensus estimate called for earnings of $0.45 per share, so Zoom posted an incredible 104.4% earnings surprise.

Looking forward, I expect Zoom to continue to outperform the broader market and its peers, as demand remains strong for its platform for the foreseeable future. And I’m not alone. The analyst community has increased third-quarter earnings estimates by 123.5% in the past three months. For its third quarter in fiscal year 2021, earnings are expected to surge 744% year-over-year to $0.76 per share and revenue is forecast to soar 315.4% year-over-year to $692.05 million. ZM is an Aggressive buy below $601.

SOM Technicals:

7-30-20: Closed at 253.91. Trade pressures are down but rising into the neutral zone. Volumes are bearish. The next target down is 209.79.

8-7-20: Closed at 258.73. Trade pressures are down. Volumes are Bearish. The next target down is 239.12.

8-15-20: Closed at 244.91. Trade pressures are up. Volumes are bearish. Rising into net bearish volumes after reaching the 227.53. target. Need to get thru the 25×5 MA at 254.63, otherwise more downside.

8-21-20: Closed at 289.68. Trade pressures are up and trending. Volumes are bullish. The resistance was non- existent. A new long entry was triggered at 271.00.

8-29-20: Closed at 299.27. Trade pressures are up. Volumes are bullish. The next target up is 314.82.

9-5-20: Closed at 369.89. Trade pressures are down into the neutral zone. Volumes are bullish. The next target down is 314.78 which would close the gap up. 

9-12-20: Closed at 383.00. Trade pressures are now up. Volumes are bearish. A close below 376 would signal a new leg down.

9-19-20: Closed at 438.73. Trade pressures are up. Volumes are bullish. In the new move after a back test to try to close the gap a t 345. The next target up is 470.76.

9-26-20: Closed at 496.50. Trade pressures are up but declining. Volumes are now neutral. The next target down is 452.23.

10-11-20: Closed at 492.41. Trade pressures up Volumes are bullish. The next target up is the 529.74  prior high.

10-17-20: Closed at 559.00. Trade pressures are up and trending. Volumes are bullish. the next target up is 594.76.

10-24-20: Closed at 511.52. Trade pressures are down. Volumes are bearish. The next target down is 487.96.

S&P 500 Futures

#emini #spfutures #SP500 #ES

Market Pressures_

Copper is in a new leg up. Gold and Silver remain in consolidation.

Crude oil is retesting the downtrend resistance line. Nat Gas is in the move down.

The US treasury market is in a trading move up. FED comments expect no rate increases for some time.

The US Dollar futures are basing and look higher.

_______________________

S&P 500 Futures_

Monthly – Retracing in the move up. Trade pressures are up. Volumes closed the month of August as bullish but with a much lower volume. The next target up is the prior high at 3576. A close below 3290 would confirm any weekly move lower.

Weekly – Retracing the move up. Trade pressures are up but rolling over. Volumes are bearish. The next target up would be a retest of the high pivot at 3576. A close below 3273 would confirm any daily move lower.

Daily – Short. In the move down from 3350 in the second leg after the lower high mid week. Trade pressures are down. Volumes are bearish. The next target down is 3239. Need a close above 3491 to restart the move up.

_______________________

Navellier Top 5 Stocks – This Top 5 model portfolio begins the year at $100,000. Only the Top 5 Growth stocks will be tracked this 2020 year.

The Top 5 portfolio stocks countered the market sell off  this last week. The portfolio stocks were up for the week and are now valued at approximately $116,000, up 16% for the YTD.

The portfolio fundamentals continue to be important as the market narrows.

[The author may have long or short positions in any of the securities mentioned.]

S&P 500 Futures

#emini #spfutures #SP500 #ES

Market Pressures_

Copper is looking lower. Gold and silver are tracking each other sideways.

Crude Oil is lower but expecting a retracement up.

The US 30 Treasury Bond is moving up but will take it’s cue from the US Dollar.

The US Dollar futures are basing and look higher.

___________________

S&P Futures_

Monthly – Trading down hard in the September month. Trade pressures are still up. The Volumes closed the month of August as bullish. The next target up is the 3576 prior high. A close below 3300 will equal the new weekly signal lower.

Weekly – In a retracement down of the prior move up. Trade pressures are up and extended. Volumes are now neutral. The next target up is the prior high at 3576.The next target down at 3273 is the new short entry signal and would confirm any daily move lower.

Daily – A down week, but the 3273 new short entry is not yet triggered. Trade pressures are down and trending. Volumes are bearish. The next target down is that new short entry art 3275. A close above 3358 would signal a retracement move up to test resistance.

_______________________

Navellier Top 5 Stocks – This Top 5 model portfolio begins the year at $100,000. Only the Top 5 Growth stocks will be tracked this 2020 year.

The Top 5 portfolio stocks continued the sell off  this last week. The portfolio stocks were flat for the week and are still valued at approximately $110,000, now up 10% for the YTD.

The portfolio fundamentals continue to be important as the market narrows.

[The author may have long or short positions in any of the securities mentioned.]

S&P 500 Futures

#emini #spfutures #SP500 #ES

Market Pressures_

Copper has moved back to the prior highs. Gold and Silver are consolidating around 1950 and 28.

Crude oil has broken down. Natgas is in a retracement down.

The US 30 year Treasury bonds are down with the equity markets, not normal.

The US Dollar futures have met the downside targets and are not showing bullish volumes coming in.

_______________________

S&P 500 Futures_

Monthly – In the move up[ from the 2845 long entry. Trade pressures are up. Volumes closed the month of August as bullish. The next target up is 3948. A close below 2953 would confirm any weekly move lower.

Weekly – In the move up from the 2430 long entry. Trade pressures are up. volumes are bullish. The next target up is 3642. A close below 3255 would confirm ant daily move lower.

Daily – Flat. In the move up from the 3173 long entry. Trade pressures are down. Volumes are bullish. The next target up is 3980. A close below 3283 would signal a new move lower. The 25×5 MA at 3345 is acting as support. The 200 day at 3076 is a likely downside target.

_______________________

Navellier Top 5 Stocks – This Top 5 model portfolio begins the year at $100,000. Only the Top 5 Growth stocks will be tracked this 2020 year.

The Top 5 portfolio stocks rallied with the ZOOM earnings reports during this last week. The portfolio stocks were up 3% for the week and valued at approximately $110,000, now up 10% for the YTD. The portfolio was up 23% at one point before the selloff late in the week.

The portfolio fundamentals continue to be important as the market narrows.

[The author may have long or short positions in any of the securities mentioned.]

S&P 500 Futures

#emini #spfutures #SP500 #ES

Market Pressures_

Copper is moving with the equity markets. Gold and silver both in consolidation inside a retracement move down.

Crude oil is waiting for the producers to further restrict supply. Natural gas remains in the move up towards the 3.00 levels.

The US 30 year Treasury Bond is retracing inside the move up.

The US Dollar futures are trying to move off the recent lows.  May have one more leg down.

_______________________

S&P 500 Futures_

Monthly – In the move up. Trade pressures are up. Volumes closed the month of July as Bullish. August volumes appear much lower. The next target up is 3948. A close below 3223.41 would confirm any weekly move lower.

Weekly – Continues in the move up. Trade pressures are up. Volumes are bullish. The next target up is 3582. A close below 3223 would confirm many daily move lower.

Daily – Flat. In the move up. Friday broke up out of a small downward channel to resume the larger move up. Trade pressures are up. Volumes are bullish. The next target up is 3576. A close below 3363 would signal a new move lower.

_______________________

Navellier Top 5 Stocks – This Top 5 model portfolio begins the year at $100,000. Only the Top 5 Growth stocks will be tracked this 2020 year.

The Top 5 portfolio stocks dropped with earnings reports during this last week. The portfolio stocks were down 5% for the week and valued at approximately $107,000, now up 7% for the YTD. The portfolio fundamentals continue to be important as the market narrows.

DexCom (DXCM) and Genmab (GMAB) will be replaced at the open on Monday with Kroger (KR) and West Pharmaceuticals (WST).

 

[The author may have long or short positions in any of the securities mentioned.]

Navellier Top 5 for September

The following is provided by Navellier with technical comment from South Ocean Management – pls do your own due diligence.
(For this 2020 year, SOM will track only the Top 5 Hi-Growth Investments.)

https://navelliergrowth.investorplace.com/

Navellier says,

High-Growth Investments

DocuSign, Inc.

DocuSign, Inc. (DOCU) has earned its spot on the Top 5 Stocks list for the third-straight month, thanks to strong institutional buying pressure and triple-digit forecasted earnings growth. The reality is that the company has experienced a massive surge in demand for its cloud-based platform that enables businesses and individuals to develop, upload, sign and send agreements and documents virtually.

Its e-signature technology can be easily integrated with several solutions, including Salesforce and Workday. So, it’s been a popular resource in the current work-from-home climate.

DocuSign will release second-quarter results after the stock market closes on Thursday, September 3. The consensus estimate calls for earnings of $0.08 per share, which represents 700% annual earnings growth. Second-quarter revenue is forecast to jump 35.2% year-over-year to $318.57 million, up from $235.6 million in the same quarter a year ago.

Analysts’ earnings estimates have remained relatively steady over the past three months, but DocuSign has posted an average 142% earnings surprise in the past three quarters. So, I wouldn’t be surprised if DocuSign tops analysts’ estimates again. DOCU is a Moderately Aggressive buy below $243.

SOM Technicals:

6-26-20: Closed at 177.58. Trade pressures are up. Volumes are bullish. This spike up is not likel;y to continue in the face of the sell off.

7-4-20: Closed at 190.99. Trade pressures are up. Volumes are bullish. This parabolic move is very uncomfortable.

7-10-20: Closed at 210.11. Trade pressures are up but reversing. A close below 210 would signal lower.

7-18-20: Closed at 196.42. Trade pressures are down but rising. Volumes are neutral. The next target up is 217.

7-24-20: Closed at 190.95. Trade pressures are down. Volumes are bearish. The next target down is 172.23.

7-30-20: Closed at 217.45. Trade pressures are up. Volumes are bullish. The next target up is 257.20.

8-7-20: Closed at 205.00. Trade pressures are down. Volumes are bearish. Dropped thru two downside targets this week. The next target down is 185.06.

8-15-20: Closed at 199.71. Trade pressures are neutral. Volumes are neutral also. Traded down near the 185.06 target and now has moved higher. At the 25×5 MA and looks lower. The next target don is the 185.91 Target.

8-21-20: Closed at 210.18. Trade pressures are up but showing reversal. Volumes are bullish. The next target up is 221.00.

8-29-20: Closed at 215.24. Trade pressures are up. Volumes are bearish. resistance here at the 217.23 level, which is also the new long entry.

9-5-20: Closed at 216.26: Trade pressures are down. Volumes are bearish. Sitting on the 25×5 MA support at 216.

9-12-20: Closed at 197.94. Trade pressures are down. Volumes are bearish. A close below 196.53 triggers a new short entry.

9-19-20: Closed at 194.42. Trade pressures are down. Volumes are neutral. The next target down is 173.35.

 

 

The Kroger Company

The Kroger Company (KR) is one of the biggest food manufacturing businesses in the U.S., and we added it to the High-Growth Investments Buy List in the August Monthly Issue. Kroger has benefited from the global pandemic, as it has driven more Americans to its online platform, physical stores and pharmacies. And more folks are likely to be knocking down its door, as the company announced recently that it was providing COVID-19 testing at all of its clinic locations.

Kroger is expected to announce second-quarter results in early September. Given strong demand for its services and groceries, the analyst community has upped its earnings forecasts over the past three months. The current consensus estimate calls for second-quarter earnings of $0.50 per share and total sales of $29.62 billion, which represents 5.2% annual sales growth and 13.6% annual earnings growth.

Kroger also continues to reward its shareholders. The company will pay a quarterly dividend of $0.18 per share on Tuesday, September 1. All shareholders of record on August 13 will receive the dividend. The stock has a 2.0% dividend yield. KR is a Conservative buy below $38.

SOM Technicals:

Closed at 35.30. Trade pressures are down. Volumes are bearish. The next short entry is 34.51.

9-5-20: Closed at 35.47. Trade pressures are down. Volumes are bearish. New short entry at 34.84.

9-12-20: Closed at 34.30. Trade pressures are down. volumes are bearish. The next target down is 31.34.

9-19-20: Closed at 33.21. Trade pressures are down but rising. Volumes are bearish. Resistance at 35.08 and the next target down is 31.34.

 

Quidel Corporation

Quidel Corporation (QDEL) is making its second-straight appearance on the Top 5 Stocks list since we added it to the High-Growth Investments Buy List in the July Monthly Issue. The company focuses on developing diagnostic tests in the healthcare field, so its business has been booming amidst the coronavirus pandemic.

In fact, Quidel received an emergency use authorization (EUA) from the FDA for its SARS-CoV-2 test, Sofia 2 SARS Antigen FIA. After the nasal swab has been taken from a potential patient with COVID-19, the test takes approximately 15 minutes to run. I should also add that Quidel’s Lyra Direct SARS-CoV-2 assay received Health Canada authorization recently, and the test can now be used in Canada to test for the coronavirus. Needless to say, demand for Quidel’s products remains strong.

Now, as I noted in my August 27 update, QDEL pulled back sharply on Thursday, and the reason why is two-fold. First, the CDC announced this week that it had adjusted its guidelines for the testing of COVID-19. The agency will now exclude individuals who do not have symptoms of the virus. And, second, Abbott Laboratories (ABT) received an EUA from the FDA for its 15-minute COVID-19 test.

Clearly, Wall Street thinks the CDC’s recent announcement and Abbott Labs’ test will cut down on demand for Quidel’s COVID-19 tests. But I think these fears are overblown. With colleges and universities reopening their doors to students in recent weeks, many are requiring COVID-19 tests for students and professors who will be on campus. So, I suspect that demand for Quidel’s COVID-19 tests will remain in top demand for the foreseeable future.

I’m not alone in this thinking. The analyst community has upped their third-quarter earnings forecasts by a whopping 456% in the past three months. Third-quarter earnings are now expected to surge 480% year-over-year. And the company has posted a positive earnings surprise for three-straight quarters. So, I view this week’s dip as a good buying opportunity. QDEL is an Aggressive buy below $187.

SOM Technicals:

7-30-20: Closed at 282.47. Trade pressures are up. Volumes are bullish. The next target up is 367.57.

8-7-20: Closed at 272.76. Trade pressures are down. Volumes are bearish. The next target down is 259.83 the 25×5 MA.

8-15-20: Closed at 245.93. Trade pressures are up. Volumes are bearish. At the 25×5 MA. Should act as resistance. The next target down is 215.00.

8-21-20: Closed at 241.52. Trade pressures are in the neutral zone. Volume are bearish. Appears to want to test the 200.00 support level.

8-29-20: Closed at 162.97. Trade pressures are down hard. Volumes are neutral, short covering? The 200 day MA held as support. A close above 188.83 is the new long entry.

9-5-20: Closed at 154.41. Trade pressures are down. Volumes are bearish. 200 day MA is holding as support.

9-12-20: Closed at 161.19. Trade pressures are rising into the neutral zone. Volumes are now bullish. A close above 188.63 would signal higher.

9-19-20: Closed at 188.50. Trade pressures are up. Volumes are bullish. Has triggered a new long entry. The next target up is 248.00.

 

West Pharmaceutical Services, Inc.

West Pharmaceutical Services, Inc. (WST) was one of our new additions to the High-Growth Investments Buy List in the August Monthly Issue. You may recall that West Pharmaceutical Services manufactures quality containment, packaging and drug delivery products at its nearly 50 locations around the world. The company manufactures more than 100 million components each day.

With several biotechs and biopharmaceutical companies developing vaccines and treatments for the coronavirus, West Pharmaceutical Services experienced an increase in demand for its high-value products. The company reported that second-quarter sales rose 12.2% year-over-year to $527.7 million, while adjusted earnings soared 40% year-over-year to $1.25 per share.

Analysts expect product demand to remain strong in the current quarter, as evidenced by the recent earnings revisions. The current consensus estimate calls for earnings of $0.99 per share, up from previous forecasts for $0.84 per share just two months ago. Analysts also expect sales to grow 12% year-over-year to $510.68 million. WST is a Conservative buy below $293.

SOM Technicals:

Closed at 271.32: Trade pressures are down. Volumes are bearish. The next target down is 253.48.

9-5-20: Closed at 263.66. Trade pressures are down. Volumes are bearish. Next target down is 256.43.

9-12-20: Closed at 272.41. Trade pressures are up but rolling over. Volumes are bearish. At the 25×5 resistance now – 273.

9-19-20: Closed at 277.73. Trade pressures are down but rising. Volumes are bullish. Back testing the 25×5 resistance at 277 now.

 

Zoom Video Communications, Inc.

Zoom Video Communications, Inc. (ZM) is gearing up for a blowout second-quarter earnings report on Monday, August 31. The company’s business has been booming in 2020, as Zoom is a leading provider of online video and audio conference calls, as well as collaboration, chat and webinar tools. With much of the country working remotely during the pandemic, its platform has been in top demand, which should be apparent in the second-quarter results.

For the second quarter, earnings per share are expected to surge 462.5% year-over-year to $0.45, up from $0.08 per share in the same quarter a year ago. Analysts have also upped earnings forecasts by a whopping 309% in the past three months. Typically, positive analyst revisions precede future earnings surprises.

I should add that Zoom has posted an average 284% earnings surprise in the past four quarters. So, another stunning earnings surprise is likely on Monday afternoon. The company is also expected to report second-quarter revenue of $500.45 million, up 243.2% from the $145.8 million achieved in the second quarter of 2019. ZM is an Aggressive buy below $360.

SOM Technicals:

7-30-20: Closed at 253.91. Trade pressures are down but rising into the neutral zone. Volumes are bearish. The next target down is 209.79.

8-7-20: Closed at 258.73. Trade pressures are down. Volumes are Bearish. The next target down is 239.12.

8-15-20: Closed at 244.91. Trade pressures are up. Volumes are bearish. Rising into net bearish volumes after reaching the 227.53. target. Need to get thru the 25×5 MA at 254.63, otherwise more downside.

8-21-20: Closed at 289.68. Trade pressures are up and trending. Volumes are bullish. The resistance was non- existent. A new long entry was triggered at 271.00.

8-29-20: Closed at 299.27. Trade pressures are up. Volumes are bullish. The next target up is 314.82.

9-5-20: Closed at 369.89. Trade pressures are down into the neutral zone. Volumes are bullish. The next target down is 314.78 which would close the gap up. 

9-12-20: Closed at 383.00. Trade pressures are now up. Volumes are bearish. A close below 376 would signal a new leg down.

9-19-20: Closed at 438.73. Trade pressures are up. Volumes are bullish. In the new move after a back test to try to close the gap a t 345. The next target up is 470.76.

 

S&P 500 Futures

#emini #spfutures #SP500 #ES

Market Pressures_

Copper is showing lower. Gold and silver are both in a retracement down after the big move up.

Crude oil is in a the flat sideways move. Natural gas made a big move up and si now in increasing daily ranges as it tries to find new direction.

The US 30 year Treasury is testing resistance after a move down.

The US Dollar futures are experiencing some short covering.

______________________

S&P 500 Futures_

Monthly – New highs. Trade pressures are up. Volumes closed the month of July as bullish. The next target up is 3948. A close below 2928 would confirm any weekly move lower.

Weekly – In the move up. Trade pressures are up. Volumes are bullish. The next target up is 3485. A close below 3110 would confirm any daily move lower.

Daily – Flat. Moving up through old highs. Trade pressures are up but declining. Volumes remain bullish. The next target up is 3540. The stochastic indicators are all showing over bought. A close below 3306 would signal lower.

_______________________

Navellier Top 5 Stocks – This Top 5 model portfolio begins the year at $100,000. Only the Top 5 Growth stocks will be tracked this 2020 year.

The Top 5 portfolio stocks rallied with earnings reports during this last week. The portfolio stocks are up 5% for the week and valued at approximately $112,000, now up 12% for the YTD. The portfolio fundamentals continue to be important as the market narrows.

 

[The author may have long or short positions in any of the securities mentioned.]

S&P 500 Futures

#emini #spfutures #SP500 #ES

Market Pressures_

Copper follows the equity markets and is show some strength, but a failure would trigger a short. Gold and silver sold off hard but bounced right back.

Crude Oil is in the long side ways channel. Natural Gas is in a move up and looks higher still.

The US treasury Bonds are near a new short entry. Just be aware of the stimulus talks.

The US Dollar futures have sold off hard and are now oversold.

_______________________

S&P 500 Futures_

Monthly – Touched a new high intraday. Trade pressures are up. Volumes closed the month of July as Bullish. The next target up is 2289. A close below 2827 would confirm any weekly move lower.

Weekly – In the move up from the 2430 April long entry. Trade pressures are up. Volumes are bullish. The next target up is 3485. A close below 3096 would confirm any daily move lower.

Daily – In the move up from the 2835 May long entry. Trade pressures are up but reversing. Volumes are bullish.

The next target up is 3420.00.

A close below 3293 would signal a new move down.

_______________________

Navellier Top 5 Stocks – This Top 5 model portfolio begins the year at $100,000. Only the Top 5 Growth stocks will be tracked this 2020 year.

The Top 5 portfolio stocks sold off during this last week. The portfolio stocks are down 5% for the week and valued at approximately $107,000, now up 7% for the YTD. We exceeded the 13% gains from the first two months of 2020 early in the prior week; but couldn’t hold them into the week’s close. The portfolio fundamentals continue to be important as the market narrows.

 

[The author may have long or short positions in any of the securities mentioned.]

S&P 500 Futures

#emini #spfutures #SP500 #ES

Market Pressures_

Copper is in a retracement after the growth stocks sold off. Gold and silver had some profit taking also.

Crude oil rallied to the high end of the range. Nat gas is in a nice move up.

The US Treasuries are In a retracement after a move up.

The US dollar futures have a bullish weekly volume bar in the move down, but no reversal yet.

_______________________

S&P 500 Futures_

Monthly – Another monthly high is this recovery run up. Trade pressures are up. Volumes closed the month of July as bullish. The next target up is 3389. A close below 2927 would confirm any weekly move lower.

Weekly – Near the Q1 prior high at 3375. Trade pressures are up. Volumes are bullish. The next target up is 3485. A close below 3061 would confirm any daily move lower.

Daily – Still in the move up. Trade pressures are up. Volumes are bullish. the next target up is 3375. A close below 3276 would signal lower.

_______________________

Navellier Top 5 Stocks – This Top 5 model portfolio begins the year at $100,000. Only the Top 5 Growth stocks will be tracked this 2020 year.

The Top 5 portfolio stocks rose with the market during this last week. The portfolio stocks are up 2% for the week and valued at approximately $112,000, now up 12% for the YTD. We exceeded the 13% gains from the first two months of 2020 early in the week; but couldn’t hold them into the week’s close. The portfolio fundamentals continue to be important as the market narrows.

 

[The author may have long or short positions in any of the securities mentioned.]

S&P 500 Futures

#emini #spfutures #SP500 #ES

Market Pressures_

Copper is in a retracement move down. Gold is making another run to 2000. Silver is in a new move down.

Crude oil is still in a tight range between 40-42. Nat Gas is in a second leg up in the new move up.

US 30yr Treasuries continue the move up with the new stimulus on the horizon.

The US Dollar futures are at the downside target and have attracted some short covering.

_______________________

S&P 500 Futures_

Monthly – Continues the grind higher. Trade pressures are up. Volumes closed the month of July as bullish. The next target up is 3389. A close below 2905 would confirm any weekly move lower.

Weekly – Second week of consolidation at the 3230 target level. Trade pressures are up. Volumes are bullish. The next target up is the prior high at 3375. A close below 2998. would confirm any daily move lower.

Daily – Flat. Attempted a move lower but rallied at the end of the week to get back into the rising channel. Trade pressures are up. Volumes are bullish. The next target up is 3375. A close below 3120 would signal lower. Both weekly and daily volumes remain bullish, so the odds favor higher.

_______________________

Navellier Top 5 Stocks – This Top 5 model portfolio begins the year at $100,000. Only the Top 5 Growth stocks will be tracked this 2020 year.

The Top 5 portfolio stocks rose with the market during this last week. The portfolio stocks are up 5% for the week and valued at approximately $110,000, now up 10% for the YTD. We may match the 13% gains from these first two months of 2020; but would do well to remember the down 32% lows of March. The portfolio fundamentals continue to be important as the market narrows.

Clorox (CLX, Nvidia (NVDA) and VIP Shop (VIPS) will be replaced in the portfolio by Genmab (GMAB), Quidel Corp (QDEL) and Zoom (ZM) at the Monday open.

[The author may have long or short positions in any of the securities mentioned.]